Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded update dates 2026-04-08 and 2026-04-09; removed 2026-04-02 and 2026-04-03.SummaryDifference0.0%

- Check13 days agoChange DetectedUpdated the Study Record Dates with new entries for 2026-04-02 and 2026-04-03, and removed older dates 2026-03-27, 2026-03-26, and 2025-09.SummaryDifference0.0%

- Check20 days agoChange Detected- Updated the page with new update dates (2026-03-27, 2026-03-26) and removed older dates (2026-03-20, 2026-03-19).SummaryDifference0.0%

- Check27 days agoChange DetectedAdded log entries for 2026-03-19 and 2026-03-20 and updated to Revision: v3.5.0. Deleted log entries for 2026-03-12 and 2026-03-13 and updated to Revision: v3.4.3.SummaryDifference0.0%

- Check34 days agoChange DetectedUpdates to the study page include date-stamped additions on 2026-03-12 and 2026-03-13 and deletions on 2026-03-05 and 2026-03-06.SummaryDifference0.0%

- Check41 days agoChange DetectedUniversity of Michigan Rogel Cancer Center was added as a participating site and University of Michigan Comprehensive Cancer Center was removed; the record was updated to Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.